155 related articles for article (PubMed ID: 21850438)
21. Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay.
Rojas C; Frazier ST; Flanary J; Slusher BS
Anal Biochem; 2002 Nov; 310(1):50-4. PubMed ID: 12413472
[TBL] [Abstract][Full Text] [Related]
22. N-acetylaspartylglutamate (NAAG) is the probable mediator of axon-to-glia signaling in the crayfish medial giant nerve fiber.
Gafurov B; Urazaev AK; Grossfeld RM; Lieberman EM
Neuroscience; 2001; 106(1):227-35. PubMed ID: 11564432
[TBL] [Abstract][Full Text] [Related]
23. GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity.
Thomas AG; Bodner A; Ghadge G; Roos RP; Slusher BS
J Neurovirol; 2009 Sep; 15(5-6):449-57. PubMed ID: 19995130
[TBL] [Abstract][Full Text] [Related]
24. Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis.
Hollinger KR; Alt J; Riehm AM; Slusher BS; Kaplin AI
Brain Res; 2016 Mar; 1635():105-12. PubMed ID: 26826008
[TBL] [Abstract][Full Text] [Related]
25. Identification of 2-PMPA as a novel inhibitor of cytosolic carboxypeptidases.
Wang R; Lin L; Zheng Y; Cao P; Yuchi Z; Wu HY
Biochem Biophys Res Commun; 2020 Dec; 533(4):1393-1399. PubMed ID: 33092792
[TBL] [Abstract][Full Text] [Related]
26. NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
Olszewski RT; Janczura KJ; Ball SR; Madore JC; Lavin KM; Lee JC; Lee MJ; Der EK; Hark TJ; Farago PR; Profaci CP; Bzdega T; Neale JH
Transl Psychiatry; 2012 Jul; 2(7):e145. PubMed ID: 22850437
[TBL] [Abstract][Full Text] [Related]
27. Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration.
Nagel J; Belozertseva I; Greco S; Kashkin V; Malyshkin A; Jirgensons A; Shekunova E; Eilbacher B; Bespalov A; Danysz W
Neuropharmacology; 2006 Dec; 51(7-8):1163-71. PubMed ID: 16926034
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents.
Kozikowski AP; Zhang J; Nan F; Petukhov PA; Grajkowska E; Wroblewski JT; Yamamoto T; Bzdega T; Wroblewska B; Neale JH
J Med Chem; 2004 Mar; 47(7):1729-38. PubMed ID: 15027864
[TBL] [Abstract][Full Text] [Related]
29. Glutamate carboxypeptidase II does not process amyloid-β peptide.
Sedlák F; Šácha P; Blechová M; Březinová A; Šafařík M; Šebestík J; Konvalinka J
FASEB J; 2013 Jul; 27(7):2626-32. PubMed ID: 23525279
[TBL] [Abstract][Full Text] [Related]
30. Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate.
Bacich DJ; Ramadan E; O'Keefe DS; Bukhari N; Wegorzewska I; Ojeifo O; Olszewski R; Wrenn CC; Bzdega T; Wroblewska B; Heston WD; Neale JH
J Neurochem; 2002 Oct; 83(1):20-9. PubMed ID: 12358725
[TBL] [Abstract][Full Text] [Related]
31. Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II.
Barinka C; Rovenská M; Mlcochová P; Hlouchová K; Plechanovová A; Majer P; Tsukamoto T; Slusher BS; Konvalinka J; Lubkowski J
J Med Chem; 2007 Jul; 50(14):3267-73. PubMed ID: 17567119
[TBL] [Abstract][Full Text] [Related]
32. Expression and acquisition of the conditioned place preference response to cocaine in rats is blocked by selective inhibitors of the enzyme N-acetylated-alpha-linked-acidic dipeptidase (NAALADASE).
Slusher BS; Thomas A; Paul M; Schad CA; Ashby CR
Synapse; 2001 Jul; 41(1):22-8. PubMed ID: 11354010
[TBL] [Abstract][Full Text] [Related]
33. NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.
Olszewski RT; Janczura KJ; Bzdega T; Der EK; Venzor F; O'Rourke B; Hark TJ; Craddock KE; Balasubramanian S; Moussa C; Neale JH
Neurochem Res; 2017 Sep; 42(9):2646-2657. PubMed ID: 28285415
[TBL] [Abstract][Full Text] [Related]
34. In silico approaches to identify the potential inhibitors of glutamate carboxypeptidase II (GCPII) for neuroprotection.
Naushad SM; Janaki Ramaiah M; Stanley BA; Prasanna Lakshmi S; Vishnu Priya J; Hussain T; Alrokayan SA; Kutala VK
J Theor Biol; 2016 Oct; 406():137-42. PubMed ID: 27430729
[TBL] [Abstract][Full Text] [Related]
35. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3.
Berent-Spillson A; Robinson AM; Golovoy D; Slusher B; Rojas C; Russell JW
J Neurochem; 2004 Apr; 89(1):90-9. PubMed ID: 15030392
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships of glutamate carboxypeptidase II (GCPII) inhibitors.
Ferraris DV; Shukla K; Tsukamoto T
Curr Med Chem; 2012; 19(9):1282-94. PubMed ID: 22304717
[TBL] [Abstract][Full Text] [Related]
37. Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat.
Carpenter KJ; Sen S; Matthews EA; Flatters SL; Wozniak KM; Slusher BS; Dickenson AH
Neuropeptides; 2003 Oct; 37(5):298-306. PubMed ID: 14607107
[TBL] [Abstract][Full Text] [Related]
38. Rationally designed sulfamides as glutamate carboxypeptidase II inhibitors.
Choy CJ; Fulton MD; Davis AL; Hopkins M; Choi JK; Anderson MO; Berkman CE
Chem Biol Drug Des; 2013 Nov; 82(5):612-9. PubMed ID: 23773397
[TBL] [Abstract][Full Text] [Related]
39. Effects of selective inhibition of N-acetylated-alpha-linked-acidic dipeptidase (NAALADase) on mice in learning and memory tasks.
Lukawski K; Kamiński RM; Czuczwar SJ
Eur J Pharmacol; 2008 Jan; 579(1-3):202-7. PubMed ID: 18031726
[TBL] [Abstract][Full Text] [Related]
40. Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration.
Rais R; Wozniak K; Wu Y; Niwa M; Stathis M; Alt J; Giroux M; Sawa A; Rojas C; Slusher BS
PLoS One; 2015; 10(7):e0131861. PubMed ID: 26151906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
